Navigation Links
Biogenics Research Chamber Announces Facility Extension
Date:5/9/2013

San Antonio, Texas (PRWEB) May 09, 2013

Biogenics Research Chamber (http://www.biogenicschamber.com), a unique allergy testing facility in San Antonio, Texas, has broken ground on an extension. The 5,400 square feet will house a large allergy exposure chamber, a specialty chamber, and eye examination rooms. The chambers will utilize clean room technology with complete electrical back-up by generator. The extension will enhance capacity for simultaneous testing of large numbers of participants, while broadening therapeutic testing capabilities.

Dr. Robert Jacobs, founder and co-owner, noted that “It is amazing to think that we have outgrown our existing chambers in just three short years. We are excited to be the U.S. leaders in this area of research.”

Biogenics Research Chamber, the only large permanent pollen exposure chamber in the United States, opened in 2010 in the Medical Center of San Antonio. Projects have included pharmaceutical and vaccine trials and scientific studies elucidating the basic mechanisms and genetics of allergy. The extension, scheduled for completion in January 2014, is engineered to challenge with seasonal pollens as well as year-round allergy-provoking agents including dust mites and cat dander. The specialty chamber is designed for testing of novel agents for non-allergic eye and respiratory conditions.

About the Company:
Dr. Robert L. Jacobs, Dr. Daniel A. Ramirez and Dr. Charles P. Andrews are the owners and Principal Investigators of the Biogenics Research Chamber located in San Antonio, Texas. The facility has challenge chambers designed to conduct allergic and non-allergic exposure studies in a controlled environment that utilizes clean room technology. Proof of concept, dose-ranging, and onset of action studies are performed for pharmaceutical and vaccine trials. For companies investigating new products, the chambers offer the advantage of concentrating resources with the potential to shorten medication and vaccine development times.
                                                                    ###

Read the full story at http://www.prweb.com/releases/2013/5/prweb10697751.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. GeneTex Introduces New Mouse Monoclonal Antibody Against the Ten-Eleven Translocation 1 (TET1) Protein for DNA Methylation/Epigenetics Research
2. Core Facility Management Software Company Builds API to Extend Complex Workflows in Research
3. The Alliance for the Advancement of Adult Stem Cell Therapy and Research Recently Has Proven Stem Cells To Be Effective in Dilated Cardiomyopathy
4. Cell Culture Market is Expected to Reach USD 16.85 Billion Globally in 2018: Transparency Market Research
5. Peripheral Vascular Devices Market is Expected to Reach USD 7.8 Billion Globally in 2018: Transparency Market Research
6. Real Time Genomics and J. Craig Venter Institute Embark on Strategic Research Initiative
7. David Hooper Joins Evolution Marketing Research as Senior Director, Research
8. Averica Discovery Services and Worcester Polytechnic Institute Establish Research Collaboration
9. Heptares Achieves All Research Milestones and Receives Milestone Payment From GPCR Drug Discovery Agreement With Takeda
10. Society for Women’s Health Research IMAGINES IT -- SWHR’s Annual Gala Imagines the Future: Information Technology (IT) Transforms Women’s Healthcare
11. Altogen Labs Offers New Pre-Clinical CRO Services to Accelerate Pre-Clinical Research Needs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... 23, 2017 In today,s pre-market ... in the Biotech industry: Sangamo Therapeutics Inc. (NASDAQ: SGMO), ... MKT: SYN), and Regulus Therapeutics Inc. (NASDAQ: ... Credit Suisse upgraded its rating on Pharmaceuticals/Biotechnology to "Overweight" from "Market Weight." ... report at: ...
(Date:3/22/2017)... , March 22, 2017 Regeneron Pharmaceuticals, Inc. (NASDAQ: ... Genetics Center (RGC), U.K. Biobank and GSK to generate genetic ... Biobank resource. The initiative will enable researchers to gain valuable ... for a wide range of serious and life threatening diseases. ... Genetic ...
(Date:3/22/2017)... COPENHAGEN, Denmark , March 22, 2017 /PRNewswire/ ... that utilizes its innovative TransCon technology to address ... announced financial results for the full year ended ... a significant year for our company as we ... become a leading, integrated rare disease company with ...
(Date:3/22/2017)... Mass. , March 22, 2017 Good ... that it has eclipsed the 130 million covered lives ... Blue Shield of Texas . With ... the Company continues to enjoy strong payor acceptance based ... its clinical programs and genetic counseling, its industry-leading customer ...
Breaking Biology Technology:
(Date:3/24/2017)... Mar 24, 2017 Research and Markets has ... Market Analysis & Trends - Industry Forecast to 2025" report ... ... at a CAGR of around 15.1% over the next decade to ... report analyzes the market estimates and forecasts for all the given ...
(Date:3/22/2017)... 21, 2017 Vigilant Solutions , a ... enforcement agencies, announced today the appointment of retired FBI ... public safety business development. Mr. Sheridan brings ... including a focus on the aviation transportation sector, to ... position, Mr. Sheridan served as the Aviation Liaison Agent ...
(Date:3/9/2017)... , Australia , March 9, ... study data at the prestigious World Lung Imaging Workshop ... Andreas Fouras , was invited to deliver the ... pulmonary medicine. This globally recognised event brings together leaders ... share the latest developments in lung imaging. ...
Breaking Biology News(10 mins):